These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35379594)

  • 1. The reality of cholangiocarcinoma in India- real world data from a tertiary referral centre.
    Patkar S; Gupta V; Khobragade K; Goel M
    HPB (Oxford); 2022 Sep; 24(9):1511-1518. PubMed ID: 35379594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma miscoding in hepatobiliary centres.
    Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
    Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
    Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
    Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
    Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma.
    Lurje I; Czigany Z; Eischet S; Bednarsch J; Ulmer TF; Isfort P; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
    Hepatol Commun; 2022 Sep; 6(9):2400-2417. PubMed ID: 35616275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current diagnostic and management options in perihilar cholangiocarcinoma.
    Rizvi S; Gores GJ
    Digestion; 2014; 89(3):216-24. PubMed ID: 24860985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF).
    Neuzillet C; Decraecker M; Larrue H; Ntanda-Nwandji LC; Barbier L; Barge S; Belle A; Chagneau C; Edeline J; Guettier C; Huguet F; Jacques J; Le Bail B; Leblanc S; Lewin M; Malka D; Ronot M; Vendrely V; Vibert É; Bureau C; Bourliere M; Ganne-Carrie N; Blanc JF
    Liver Int; 2024 Oct; 44(10):2517-2537. PubMed ID: 38967424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallbladder cancer mimicking perihilar cholangiocarcinoma-considerable rate of postoperative reclassification with implications for prognosis.
    Nooijen LE; Gustafsson-Liljefors M; Erdmann JI; D'Souza MA; Gilg S; Villard C; Jansson H
    World J Surg Oncol; 2023 Sep; 21(1):286. PubMed ID: 37697321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma.
    Akita M; Sofue K; Fujikura K; Otani K; Itoh T; Ajiki T; Fukumoto T; Zen Y
    HPB (Oxford); 2019 Feb; 21(2):226-234. PubMed ID: 30170977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
    Sapisochin G; Ivanics T; Heimbach J
    Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing futile surgery in Intrahepatic and Perihilar cholangiocarcinomas: Can we identify preoperative factors to improve patient selection and optimize outcomes?
    Goel M; Varty GP; Patkar S; Meghana V; Kazi M; Nandy K; Ostwal V; Ramaswamy A; Gala KB; Shetty NS
    Surg Oncol; 2024 Aug; 55():102096. PubMed ID: 38964224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
    Javle M; Lee S; Azad NS; Borad MJ; Kate Kelley R; Sivaraman S; Teschemaker A; Chopra I; Janjan N; Parasuraman S; Bekaii-Saab TS
    Oncologist; 2022 Oct; 27(10):874-883. PubMed ID: 35972334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
    Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
    BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?
    Yilmaz S; Carr BI; Akbulut S
    J Gastrointest Cancer; 2022 Dec; 53(4):1104-1112. PubMed ID: 34738188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.
    Wang Y; Li K; Zhao W; Liu Z; Liu J; Shi A; Chen T; Mu W; Xu Y; Pan C; Zhang Z
    Cell Death Dis; 2021 Dec; 12(12):1158. PubMed ID: 34907179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Textbook oncologic outcomes among patients undergoing laparoscopic, robotic and open surgery for intrahepatic and perihilar cholangiocarcinoma.
    Munir MM; Dillhoff M; Tsai S; Pawlik TM
    HPB (Oxford); 2024 Aug; 26(8):1051-1061. PubMed ID: 38825434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.